The Role of Bleeding at Implant Placement
1 other identifier
observational
102
1 country
1
Brief Summary
Angiogenesis is inherently associated to bone formation and healing. During implant osseointegration, a successive and successful angiogenic processes has to occur to promote bone formation. In 1969, Branemark et al. demonstrated that direct contact between bone and titanium implant surface was possible, defining osseointegration as "the direct, structural, and functional contact between live bone and the surface of a functionally loaded implant". Consequently, the need of an empirical measurement appeared. With the introduction of resonance frequency analysis (RFA), it is now possible to measure the degree of implant stability at any time during the course of implant treatment and loading. In this way, changes in implant stability can be monitored over the time and it is likely possible to find implants at risk of failure before they become loose. The rationale of this study is to analyse how important a good vascularization is for the future bone formation around dental implants.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Oct 2018
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2018
CompletedFirst Submitted
Initial submission to the registry
October 10, 2018
CompletedFirst Posted
Study publicly available on registry
October 15, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
January 4, 2021
CompletedMarch 31, 2023
October 1, 2018
2 years
October 10, 2018
March 30, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Correlation between bleeding during implant placement and marginal bone loss
Peri-implant bone loss after 1 year from the implant placement
1 year
Secondary Outcomes (1)
Correlation between bleeding during implant placement and implant stability quotient (ISQ) values
3 months
Eligibility Criteria
Patients who come to the Unit of Periodontology (UZ Leuven, St. Rafaël), in need of implant rehabilitation, will be evaluated for initial study eligibility during a screening visit. Patients shall be advised of the need to attend follow-up visits: 3 months after implant placement (at abutment placement visit) and 1 year, the latter to analyse the early bone remodelling.
You may qualify if:
- Males or females American Society of Anesthesiologists classification (ASA) I or II, between 18 to 80 years of age
- Patient in good general health as documented by self-assessment.
- Patients needing implant rehabilitation in the upper or lower jaw.
- Patients must be committed to the study and must be willing to sign the informed consent.
You may not qualify if:
- Any systemic medical condition that could interfere with the surgical procedure or planned treatment.
- Immunosuppression, Diabetes, Anticoagulation or Antiaggregatory medication.
- Current pregnancy or breast feeding/ lactating at the time of recruitment.
- Radiotherapy or Chemotherapy in head and neck area.
- Intravenous and oral bisphosphonate therapy.
- Patients smoking \>20 cigarettes a day.
- Unwillingness to return for the follow-up examination.
- Conditions or circumstances, in the opinion of the investigator, which could represent a general contra-indication for surgical procedure or would prevent completion of study participation or interfere with analysis of study results, such as history of non-compliance, or unrealistic expectations.
- Immediate implant placement after tooth extraction.
- Risk of extra bleeding due to inflammatory or infectious processes near the zone of implantation.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
UZ Leuven
Leuven, 3000, Belgium
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 10, 2018
First Posted
October 15, 2018
Study Start
October 1, 2018
Primary Completion
October 1, 2020
Study Completion
January 4, 2021
Last Updated
March 31, 2023
Record last verified: 2018-10